Vifor Pharma Group is a leading global pharmaceutical company that conducts research, develops, produces, and markets its own pharmaceutical products. With a strong emphasis on patient-focused solutions, the company aims to be a global leader in iron deficiency, nephrology, and cardio-renal therapies. Vifor Pharma Group operates production sites in Switzerland and Portugal and has a wide network of affiliates and partners worldwide. Additionally, CSL Vifor, a business unit of CSL, is dedicated to addressing kidney disease, particularly in the areas of iron deficiency and nephrology. Their goal is to launch the next generation of therapies to cater to the full spectrum of kidney disease, including dialysis and rare diseases.